Maria Laura Patiab,
Mauro Nisoa,
Savina Ferorellia,
Carmen Abate*a and
Francesco Berardia
aDipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari ALDO MORO, Via Orabona 4, I-70125 Bari, Italy. E-mail: carmen.abate@uniba.it; Fax: +39-080-5442231; Tel: +39-080-5442750
bDivision of Hepatobiliary, Pancreatic, and Gastrointestinal Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA
First published on 30th January 2017
Correction for ‘Novel metal chelators thiosemicarbazones with activity at the σ2 receptors and P-glycoprotein: an innovative strategy for resistant tumor treatment’ by Maria Laura Pati et al., RSC Adv., 2015, 5, 103131–103146.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2017 |